bioRxiv Science⌕ Search

Biology subjects

Kissenpfennig, A.

Publications and source records attributed to Kissenpfennig, A..

4 recordsLinked to original sources

Klebsiella pneumoniae remodels its Kdo2-lipid A in a TLR4-dependent manner to adapt to the macrophage intracellular environment

Pathogen adaptations to the intracellular macrophage environment remain poorly understood. We performed a high-resolution structural analysis of the lipid A purified from intracellular Klebsiella pneumoniae (KP). In both mouse and human macrophages, KP produces hexa- and hepta-acylated lipid A species modified with palmitate and 2-hydroxylated. LpxL1, PagP, and LpxO enzymes govern the intracellular lipid A in a PhoPQ-dependent manner triggered by the acidic pH of the KP-containing vacuole (KCV). Absence of LpxO and PagP lipid A modifications impairs intracellular survival and heightens NF-{kappa}B and IRF3-mediated inflammation, though KCV maturation remains unaffected. Instead, these modifications fortify the bacterial membrane. Absence of TLR4-TRAM-TRIF signalling increases KCV pH, impairing the production of the intracellular lipid A. KP intracellular survival is reduced in tlr4-/- macrophages, highlighting the critical role of this signalling pathway in KP immune evasion and how the pathogen has evolved to rely on innate immune system cues for virulence.

microbiology↗

In vivo single-cell high-dimensional mass cytometry analysis to track the interaction between Klebsiella pneumoniae and myeloid cells.

In vivo single-cell approaches have transformed our understanding of the immune populations in tissues. Mass cytometry (CyTOF), that combines the resolution of mass spectrometry with the ability to conduct multiplexed measurements of cell molecules at the single cell resolution, has enabled to resolve the diversity of immune cell subsets, and their heterogeneous functionality. Here we assess the feasibility of taking CyTOF one step further to immuno profile cells while tracking their interaction with bacteria, a method we term Bac-CyTOF. We focus on the pathogen Klebsiella pneumoniae interrogating the pneumonia mouse model. Using Bac-CyTOF, we unveil the atlas of immune cells of mice infected with a K. pneumoniae virulent strain. The atlas is characterized by a decrease in the populations of alveolar macrophages and monocyte-derived macrophages, whereas neutrophils, and inflammatory monocytes are characterized by an increase in the subpopulations expressing markers characteristic of less active cells such as the immune checkpoint PD-L1. These cells are those with associated bacteria. We show that the type VI secretion system (T6SS) contributes to shape the lung immune landscape. The T6SS governs the interaction with monocytes/macrophages by shifting Klebsiella from alveolar macrophages to interstitial macrophages and limiting the infection of inflammatory monocytes. Lack of T6SS results in cells expressing markers of active cells, and a decrease in the subpopulations expressing PD-L1. By infecting with Klebsiella, and Acinetobacter baumannii strains cleared by mice, we uncover that a heightened recruitment of neutrophils, and relative high levels of alveolar macrophages and eosinophils and the recruitment of a characteristic subpopulation of neutrophils are features of infected mice clearing infections. Lastly, we leverage Bac-CyTOF-generated knowledge platform to investigate the role of the DNA sensor STING in Klebsiella infections. sting-/- infected mice present features of mice clearing the infection including the reduced levels of PD-L1. STING absence facilitates Klebsiella clearance. AUTHOR SUMMARYHost-pathogen interactions are vital to our understanding of infectious disease, as well as its treatment and prevention. Mass cytometry and high-dimensional single-cell data analysis have enabled to resolve the tremendous diversity of immune cell subsets, and their heterogeneous functionality. Here we take this technology one step further to immuno profile cells in vivo while tracking their interaction with bacteria, a method we term Bac-CyTOF. Using this technology, we unveil the atlas of lung immune cells following infection with the human pathogen Klebsiella pneumoniae. The atlas is characterized by an increase in the populations expressing markers characteristic of less active cells such as the immune checkpoint PD-L1. The pathogen interacts with these cells. We uncover the contribution of the antimicrobial nanoweapon T6SS to shape the immune landscape, highlighting its potential in host defence. By probing two pathogens effectively cleared by mice, we reveal features of infections successfully cleared by mice. Lastly, we leverage this knowledge platform to investigate the role of the DNA sensor STING in Klebsiella infections. There was no prior knowledge on the role of STING in Klebsiella infection biology. Our findings suggest Klebsiella may utilize STING signalling for its own benefit because absence of STING facilitates Klebsiella clearance.

microbiology↗

In vivo single cell transcriptomics reveals Klebsiella pneumoniae rewiring of lung macrophages to promote infection

The strategies deployed by antibiotic resistant bacteria to counteract host defences are poorly understood. Here, we elucidate a novel host-pathogen interaction that results in the control of lung macrophage polarisation by the human pathogen Klebsiella pneumoniae. We identify interstitial macrophages (IMs) as the main population of lung macrophages associated with Klebsiella. Single cell transcriptomics and trajectory analysis of cells uncover that type I IFN and IL10 signalling, and macrophage polarization are characteristic of infected IMs, whereas Toll-like receptor (TLR) and Nod-like receptor signalling are features of infected alveolar macrophages. Klebsiella-induced macrophage polarization is a singular M2-type we termed M(Kp). To rewire macrophages towards M(Kp), K. pneumoniae hijacks a hitherto unknown TLR-type I IFN-IL10-STAT6 innate axis. Absence of STAT6 limits the intracellular survival of Klebsiella whereas the inhibition of STAT6 facilitates the clearance of the pathogen in vivo. Glycolysis characterises M(Kp) metabolism, and inhibition of glycolysis results in clearance of intracellular Klebsiella. We demonstrate the capsule polysaccharide is the Klebsiella factor governing M(Kp). Klebsiella also skews human macrophage polarization towards M(Kp) in a type I IFN-IL10-STAT6-dependent manner. Altogether, our work demonstrates that Klebsiella induction of M(Kp) represents a hitherto unknown strategy to overcome host restriction during pneumonia.

microbiology↗

The immunophilin protein FKBPL and its peptide derivatives are novel regulators of vascular integrity and inflammation via NF-kappaB signaling

A breakdown in vascular integrity and excessive inflammation are hallmarks of serious pathological conditions including sepsis, acute respiratory distress syndrome (ARDs) and most recently, severe COVID-19. FK506 - binding protein like (FKBPL) is a member of the immunophilin protein superfamily with potent anti-tumor activity through inhibition of angiogenesis and cancer stemness. An FKBPL-based 23mer peptide, ALM201, displayed a good safety and pharmacokinetic profile in a Phase 1a oncology clinical trial and was subsequently designated orphan drug status by the FDA in ovarian cancer. Here we describe a novel role for FKBPL and its peptides in regulating vascular integrity and cytokine production though modulating NF-{kappa}B signaling. FKBPL knockdown promoted endothelial cell barrier permeability, which was further exacerbated upon stimulation with lipopolysaccharide (LPS) and accompanied by increased expression of TNF mRNA and phosphorylation of p65(RelA). Whilst treatment with the FKBPL based pre-clinical peptide, AD-01, increased VE-cadherin endothelial tight junctions following LPS stimulation. Bone marrow derived macrophages (BMDM) from FKBPL haploinsufficient mice (Fkbpl+/-) also demonstrated increased phosphorylation of p65(RelA) in response to LPS stimulation compared to wild-type mice. Furthermore, treatment with AD-01 inhibited p65(RelA) phosphorylation following LPS stimulation resulting in reduced NF-{kappa}B target gene expression and proinflammatory cytokine production. In an in vivo LPS survival model, Fkbpl+/- mice have reduced survival compared to wild-type mice. Moreover, treatment of wild-type mice with the clinical FKBPL-based peptide, ALM201, following LPS injection resulted in a 100% survival rate in mice at experimental endpoint, as well as an abrogation of production of pro-inflammatory cytokines, TNF and IL-6, in peritoneal lavage washings. Analysis of human genetic biobanks found an association between common genetic variants associated with FKBPL and traits associated with inflammatory disorders such as psoriasis, rheumatoid arthritis and high lymphocyte count. In summary, for the first time, we describe a novel role for FKBPL as a regulator of inflammation and vascular integrity through modulating NF-{kappa}B signaling and FKBPL based therapies demonstrate potent anti-inflammatory activity.

immunology↗